Benzinga's Volume Movers (XNPT, BBBY, BLUD, IMGN)

XenoPort Inc XNPT shares moved up 67.16% to $10.66 at 10:12 am. The volume of XNPT shares traded was 4112% higher than normal. GlaxoSmithKline Plc GSK and XNPT received approval from the US Food and Drug Administration (FDA) for the drug Horizant. Bed Bath & Beyond Inc BBBY shares rose 9.21% to $53.94. The volume of BBBY shares traded was 431% higher than normal. BBBY reported upbeat Q4 earnings. Immucor Inc BLUD shares climbed 5.71% to $21.12. The volume of BLUD shares traded was 364% higher than normal. BLUD reported upbeat Q3 results. ImmunoGen Inc IMGN shares gained 14.62% to $10.66. The volume of IMGN shares traded was 264% higher than normal. Roche announced positive results from the first randomized trial of a drug containing IMGN's DM1 cancer-cell killing agent. Read more from Benzinga's Markets.